InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,942.40
(
0.48%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,691.54
(
1.51%
)
Post# of 252524
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 59
Posts 6647
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: DewDiligence post# 36635

Tuesday, 10/31/2006 1:17:47 PM

Tuesday, October 31, 2006 1:17:47 PM

Post# of 252524
Yes, but I don't think any investors seriously thought that Sirna could reinvent itself after being a ribozyme company at the time. Phil Sharp clearly garners a lot more attention.

Rybozymes were a good idea at the time too, but didn't go anywhere.

I'm not saying that RNAi drugs will work without stumbling, as delivery and stability and targeting issues are still key, but it wasn't invented yesterday.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up